329
Participants
Start Date
February 28, 2002
Study Completion Date
April 30, 2006
latanoprost 0.005% (Xalatan)
Pfizer Investigational Site, Lahti
Pfizer Investigational Site, Turku
Pfizer Investigational Site, Tampere
Pfizer Investigational Site, Seinäjoki
Pfizer Investigational Site, Kuopio
Pfizer Investigational Site, Örebro
Pfizer Investigational Site, Rovaniemi
Pfizer Investigational Site, Ekenäs
Pfizer Investigational Site, Linköping
Pfizer Investigational Site, Mölndal
Pfizer Investigational Site, Nyköping
Pfizer Investigational Site, Stockholm
Pfizer Investigational Site, Uppsala
Pfizer Investigational Site, Helsinki
Pfizer Investigational Site, Helsinki
Pfizer Investigational Site, Jönköping
Pfizer Investigational Site, Karlstad
Pfizer Investigational Site, Kristianstad
Pfizer Investigational Site, Ludvika
Pfizer Investigational Site, Nacka
Pfizer Investigational Site, Norrköping
Pfizer Investigational Site, Norrköping
Pfizer Investigational Site, Seinajoki
Pfizer Investigational Site, Stockholm
Pfizer Investigational Site, Sundsvall
Pfizer Investigational Site, Täby
Pfizer Investigational Site, Uppsala
Lead Sponsor
Pfizer
INDUSTRY